Richard M. Pomerantz, M.D
Education/Certification M.D. - 1985
Johns Hopkins University, Baltimore MD
1986-88
Resident, Massachusetts General Hospital, Boston, MA
1988-91
Fellow, Beth Israel Hospital, Boston, MA Research and Professional Experience 1991-97
University of Rochester School ofMedicine and Dentistry
Assistant Professor Med/Cardiology 1997-date
University of Rochester School of Medicine and Dentistry
Associate Professor Med/Cardiology
2007-date
University of Rochester School of Medicine and Dentistry
Professor of Med/Cardiology
Richard M. Pomerantz, M.D., is Professor of Medicine, Clinical Chief of the Cardiology Unit, and Director of the Fellowship Training Program. Dr. Pomerantz joined the faculty in July of 1991, after completing a clinical and interventional cardiology fellowship at the Beth Israel Hospital in Boston. He performs diagnostic and interventional procedures in the Catheterization Laboratory in addition to his administrative duties in the organization and management of the Unit's operations.
In the Catheterization Laboratory, Dr. Pomerantz is involved in performing and teaching diagnostic and interventional cardiac procedures. The laboratory performs balloon angioplasty, directional and rotational atherectomy, percutaneous valvuloplasty, coronary stenting as well as intravascular ultrasound and doppler flow wire studies. The lab currently performs a large number of emergent procedures often using angioplasty and coronary stenting for the treatment of acute myocardial infarction. Dr. Pomerantz is a clinical investigator on a number of clinical cath lab-related research studies involving the use of coronary ultrasound to assess stent placement (AVID) as well as the use of new antiplatelet and anticoagulant therapies during PTCA. In the research laboratory, Dr. Pomerantz uses the rabbit iliac artery model and is currently collaborating closely with the Division of Radiation Oncology on projects involving the use of external beam and intravascular radiation in the prevention of restenosis following angioplasty in peripheral and coronary arteries as well as vascular grafts.
References Pomerantz RM, Kuntz RE, Carrozza JP, Fishman RF, Schmitt SJ, Safian RD, Baim DS. Acute and late outcome in diseased saphenous venous grafts treated by endoluminal stenting or directional atherectomy. Amer J Cardiol. 1992;70:161-167. Shammas NS, Cunningham MJ, Pomerantz RM, Francis CW. Markers of hemostatic activation in affected coronary arteries during angioplasty. Thrombosis and Haemostasis. 1994;73:672-675. Pomerantz RM, Ling FS. Distortion of stent geometry following side-branch balloon dilation through the stent in a rabbit model. Cath and Cardiovasc Diagnosis. 1997;40:422-426. Rubin P, Williams JP, Riggs PN, Bartos S, Sarac T, Pomerantz RM, Castano J, Schell M, Green RM. Cellular and Molecular Mechanisms of Radiation Inhibition of Restenosis. Part 1: Role of the Macrophage and Platelet Derived Growth Factor. Int J Radiation Oncology Biol Phys. 1998;40:929-941. |